Overview
Investment Stage
Series B
Portfolio 13
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| May 16, 2024 | Vitestro | vitestro.com | $104.92M | Netherlands |
| Veralox Therapeutics | veralox.com | $22M | United States, Maryland, Frederick | |
| Vega Therapeutics | vega-therapeutics.com | |||
| Functional Fluidics | functionalfluidics.com | United States, Michigan, Detroit | ||
| Catena Biosciences | catenabiosciences.com | Australia, New South Wales, Berkeley | ||
| Aronora | aronorabio.com | |||
| Vittoria Biotherapeutics | vittoriabio.com | |||
| Thymmune Therapeutics | thymmune.com | $7M | United States, Massachusetts, Cambridge | |
| KaloCyte | kalocyte.com | $300K | United States, Maryland, Baltimore |
Show more
Persons 3
| Date | First Name | Last Name | Title | Location | |||
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Christopher | D. Hillyer MD | General Partner | |||||
| Meg | Wood, MPH | Managing Director |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 9, 2026 | City Therapeutics Raises $99.5M in Series B Funding | City Therapeutics, Inc., a Cambridge, MA-based biopharmaceutical company developing RNA interference (RNAi)-based medicines, raised $99.5M in Series B funding. The round was led by Viking Global Investors and Sofinnova Investments with part... |
Reviews 0
FAQ about NYBC Ventures
How many startups has NYBC Ventures invested in?
NYBC Ventures has 13 portfolio companies on Parsers VC, among them Vitestro, Veralox Therapeutics and Vega Therapeutics.
What has the press written about NYBC Ventures?
Parsers VC has collected 2 articles mentioning NYBC Ventures, among them “City Therapeutics Raises $99.5M in Series B Funding” (Jun 9, 2026).
Is NYBC Ventures still active?
Yes, NYBC Ventures is active; its latest activity on Parsers VC dates from Oct 26, 2026.